Burnham Institute for Medical Research Faculty Appointed to BioFlorida’s Board of Directors
Burnham Institute for Medical Research Faculty Appointed to BioFlorida’s Board of Directors
Orlando, Fla., August 3, 2009—Burnham Institute for Medical Research at Lake Nona today announced the appointment of Dr. Stephen Gardell to the Board of Directors of BioFlorida. Dr. Gardell’s appointment was approved by BioFlorida’s Board at their July meeting. He joins the impressive roster of 38 directors representing research institutes, pharmaceutical, biotechnology and medical device companies and supporting organizations throughout the state.
Dr. Gardell, director of translational research and adjunct associate professor at Burnham Lake Nona, brings extensive experience in research technology and drug development that will support BioFlorida’s mission to create and maintain a growing bioscience industry in Florida. Dr. Gardell held senior positions at several large pharmaceutical companies, including Wyeth Laboratories, Bayer Research Center and Merck Research Laboratories, prior to joining Burnham.
“Burnham Institute is recognized as a world-class biomedical research organization. Their presence in Florida will have a significant effect on the state’s developing biotech industry. We’re delighted to have Dr. Steve Gardell join our board as he brings a wealth of experience as both an accomplished scientist and pharmaceutical research executive,” said Russell Allen, president and CEO of BioFlorida.
About Burnham Institute for Medical Research
Burnham Institute for Medical Research is dedicated to revealing the fundamental molecular causes of disease and devising the innovative therapies of tomorrow. Burnham, with operations in California and Florida, is one of the fastest growing research institutes in the country. The Institute ranks among the top four independent research institutions nationally for NIH grant funding and among the top 25 organizations worldwide for its research impact. Burnham utilizes a unique, collaborative approach to medical research and has established major research programs in cancer, neurodegeneration, diabetes, infectious and inflammatory and childhood diseases. For the past decade (1999-2009) Burnham ranked #1 worldwide in biology and biochemistry for the impact of its research publications (defined by citations per publication), according to the Institute for Scientific Information. Burnham is a nonprofit institute.
|
